ClinConnect ClinConnect Logo
Search / Trial NCT06550206

Toddlers' Responses to Strangers

Launched by UNIVERSITY OF CALIFORNIA SANTA CRUZ · Aug 9, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "The Malleability of Social Group Understanding in Infancy and Early Childhood," is exploring how children develop their social preferences and understanding of different races. The researchers want to find out if interacting with children from different races changes how kids think about race and social relationships compared to when they interact only with children of the same race.

The study is looking for children aged 5 to 7 years who are typically developing and speak English. If your child fits this description, they may be eligible to participate. During the trial, children will engage in activities that allow them to interact with peers from various racial backgrounds. This could help researchers understand how these interactions influence children's social behavior and perceptions about race. If you’re interested in this study, it’s a great opportunity for kids to learn and grow in a diverse environment!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • typically developing
  • age 13-24 months
  • Exclusion Criteria:
  • - any known developmental delays

About University Of California Santa Cruz

The University of California, Santa Cruz (UCSC) is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, UCSC leverages its diverse expertise in fields such as biology, psychology, and health sciences to conduct cutting-edge research. The university's clinical trial initiatives focus on addressing pressing health challenges, fostering the translation of research findings into effective interventions, and enhancing patient care. Committed to ethical standards and community engagement, UCSC strives to contribute meaningful advancements in medical science and to promote the well-being of the populations it serves.

Locations

Santa Cruz, California, United States

Patients applied

0 patients applied

Trial Officials

Hyesung Hwang, PhD

Principal Investigator

University of California Santa Cruz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported